Potassium Citrate is Used to Alkalinize Urine
Potassium citrate is an alkalinizing agent that raises urinary pH by providing an alkali load when metabolized. This is its fundamental mechanism of action and the basis for all its clinical indications 1.
Mechanism of Alkalinization
When potassium citrate is administered orally, the absorbed citrate is metabolized to produce an alkaline load, which increases urinary pH and raises urinary citrate levels by augmenting citrate clearance 1. The medication increases urinary pH by approximately 0.7 units at a dosage of 60 mEq/day 1. This alkalinization effect begins within the first hour after a single dose and lasts for 12 hours 1.
Clinical Indications for Urinary Alkalinization
Primary Indications (FDA-Approved)
Potassium citrate is indicated for three specific conditions where alkaline urine is therapeutic 1:
Renal tubular acidosis (RTA) with calcium stones - where urinary pH may already be high but citrate supplementation is still needed 1
Hypocitraturic calcium oxalate nephrolithiasis - regardless of etiology 1
Uric acid lithiasis - with or without calcium stones 1
Guideline-Supported Uses
The 2014 AUA Guidelines provide specific recommendations for alkalinization:
Recurrent calcium stones with hypocitraturia: Offer potassium citrate to patients with low or relatively low urinary citrate (Grade B evidence) 2. This includes calcium phosphate stone formers, as citrate is a potent inhibitor of calcium phosphate crystallization 2.
Uric acid stones: Potassium citrate is first-line therapy for uric acid stones, as most patients have low urinary pH rather than hyperuricosuria as the predominant risk factor 2. Target urinary pH should be raised to 6.0 2.
Cystine stones: Offer potassium citrate to raise urinary pH to an optimal level of 7.0 2. This is part of first-line therapy along with increased fluid intake and dietary modifications 2.
Calcium stones with normal citrate but low urinary pH: These patients may also benefit from citrate therapy 2.
How Alkalinization Prevents Stones
The alkaline urine produced by potassium citrate prevents stone formation through multiple mechanisms 1:
- Increased citrate complexation with calcium decreases calcium ion activity and reduces calcium oxalate saturation
- Inhibition of spontaneous nucleation of calcium oxalate and calcium phosphate (brushite)
- Increased ionization of uric acid to the more soluble urate ion at higher pH
- Decreased calcium ion activity through increased calcium complexation to dissociated anions
Important Caveat
Calcium phosphate stones are more stable in alkaline urine 1. Potassium citrate does not alter the urinary saturation of calcium phosphate because the effect of increased citrate complexation is opposed by pH-dependent dissociation of phosphate 1. This is why monitoring is essential.
Target pH Levels by Stone Type
- Uric acid stones: pH 6.0 2
- Cystine stones: pH 7.0 2
- Calcium stones with hypocitraturia: Generally pH 6.0-7.0 (avoid excessive alkalinization to prevent calcium phosphate precipitation)
Dosing Considerations
The rise in citrate excretion is directly dose-dependent 1. At 60 mEq/day, potassium citrate raises urinary citrate by approximately 400 mg/day 1. In pediatric distal RTA patients, 4 mEq/kg/day was required to normalize most urinary abnormalities 3.
Important limitation: In patients with severe renal tubular acidosis or chronic diarrheal syndrome where urinary citrate is very low (<100 mg/day), potassium citrate may be relatively ineffective, requiring higher doses 1.
Contraindications to Alkalinization
Potassium citrate should not be used when alkaline urine would be harmful 4:
- Urinary tract infection (especially with urease-producing organisms causing struvite stones)
- Struvite stone disease (these stones form in alkaline urine)
- Hyperkalemia or advanced chronic renal failure
- Metabolic alkalosis
The 2025 EAU Guidelines specifically recommend oral chemolysis with alkalinization (pH 7.0-7.2) for uric acid stones, with an 80.5% success rate 5.